Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00907725|
Recruitment Status : Completed
First Posted : May 25, 2009
Last Update Posted : May 10, 2012
The purpose of this study is to evaluate if BhCG testing to determine the completion of medical abortion simplifies the medical abortion protocol. Investigators hypothesize that women randomized to ultrasonographic determination of completion of medical abortion will have MORE follow-up visits/interventions beyond standard protocol than those randomized to medical abortion follow-up with serum BhCG.
The investigators also hope to explore satisfaction with BhCG based follow-up among women seeking medical abortion. Investigators hypothesize that the majority of women who choose to follow-up with serum BhCG will be satisfied with this method of medical abortion follow-up.
|Condition or disease||Intervention/treatment|
|Medical Abortion||Other: serum BhCG follow-up Other: ultrasonographic follow-up|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||376 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Follow-up With Serum BhCG Simplify Medical Abortion: A Randomized Controlled Trial|
|Study Start Date :||May 2009|
|Primary Completion Date :||June 2010|
|Study Completion Date :||June 2010|
serum BhCG follow-up
Other: serum BhCG follow-up
Subjects in this arm will receive medical abortion follow-up using BhCG blood draw
Other: ultrasonographic follow-up
Subjects in this arm will receive medical abortion follow-up by ultrasound
- Receipt of any additional intervention or follow-up beyond the one routinely scheduled follow-up ultrasound or follow-up BhCG draw [ Time Frame: 4 weeks ]
- Patient satisfaction with follow-up method [ Time Frame: 4 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00907725
|United States, Massachusetts|
|Planned Parenthood League of Massachusetts|
|Boston, Massachusetts, United States, 02215|
|Principal Investigator:||Principal Investigator||Planned Parenthood|